The Polish Competition Authority issues a conditional clearance for a merger in the pharmaceutical sector (Neuca / ACP Pharma)

In the decision of 31 March 2014, the President of the Office for Competition and Consumer Protection (hereinafter referred to as the “OCCP President”) approved concentration consisting of Neuca taking control over ACP Pharma. However, Neuca must sell one of its wholesalers located in Bydgoszcz (northern Poland). Both undertakings are active in the wholesale and pre-wholesale

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.